当前位置: 首页 > 详情页

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Med, Beijing 100029, Peoples R China; [2]China Japan Friendship Hosp, Tobacco Med & Tobacco Cessat Ctr, Ctr Resp Med, Beijing, Peoples R China; [3]China Japan Friendship Hosp, Inst Clin Med Sci, Ctr Resp Med, Beijing, Peoples R China; [4]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [5]Chinese Acad Med Sci, Beijing, Peoples R China; [6]Peking Union Med Coll, Beijing, Peoples R China; [7]Capital Med Univ, Dept Resp Med, Beijing, Peoples R China; [8]WHO, Collaborating Ctr Tobacco Cessat & Resp Dis, Beijing, Peoples R China; [9]Shanxi Dayi Hosp, Dept Pulm & Crit Care Med, Taiyuan, Shanxi, Peoples R China; [10]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [11]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [12]Guizhou Prov Peoples Hosp, Dept Pulm & Crit Care Med, Guiyang, Guizhou, Peoples R China; [13]Fudan Univ, Zhongshan Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China; [14]China Med Univ, Hosp 1, Shenyang, Liaoning, Peoples R China; [15]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [16]Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China; [17]Zhejiang Univ, Sch Med, Dept Resp & Crit Care Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [18]Sichuan Univ, West China Hosp, State Key Lab Biotherapy China, Chengdu, Sichuan, Peoples R China; [19]Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China; [20]Capital Med Univ, Dept Pulm & Crit Care Med, Beijing, Peoples R China; [21]Capital Med Univ, Dept Stomatol, Beijing Chaoyang Hosp, Beijing, Peoples R China; [22]Capital Med Univ, Dept Epidemiol, Beijing Chaoyang Hosp, Beijing, Peoples R China; [23]Beijing Inst Resp Med, Beijing, Peoples R China; [24]Peking Univ, Hosp 3, Dept Resp & Crit Care Med, Beijing, Peoples R China; [25]Beijing Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [26]Beijing Hosp, Dept Pathol, Beijing, Peoples R China; [27]Natl Ctr Gerontol, Beijing, Peoples R China; [28]Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci, Beijing, Peoples R China; [29]Capital Med Univ, Beijing Childrens Hosp, Ctr Clin Epidemiol & Evidence Based Med, Natl Ctr Childrens Hlth, Beijing, Peoples R China; [30]Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
出处:
ISSN:

摘要:
Background Although exposure to cigarette smoking and air pollution is common, the current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the Chinese adult population. We conducted the China Pulmonary Health (CPH) study to assess the prevalence and risk factors of COPD in China. Methods The CPH study is a cross-sectional study in a nationally representative sample of adults aged 20 years or older from ten provinces, autonomous regions, and municipalities in mainland China. All participants underwent a post-bronchodilator pulmonary function test. COPD was diagnosed according to 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Findings Between June, 2012, and May, 2015, 57 779 individuals were invited to participate, of whom 50 991 (21 446 men and 29 545 women) had reliable post-bronchodilator results and were included in the final analysis. The overall prevalence of spirometry-defined COPD was 8 . 6% (95% CI 7 . 5-9 . 9), accounting for 99 . 9 (95% CI 76 . 3-135 . 7) million people with COPD in China. Prevalence was higher in men (11 . 9%, 95% CI 10 . 2-13 . 8) than in women (5 . 4%, 4 . 6-6 . 2; p< 0 . 0001 for sex difference) and in people aged 40 years or older (13 . 7%, 12 . 1-15 . 5) than in those aged 20-39 years (2 . 1%, 1 . 4-3 . 2; p< 0 . 0001 for age difference). Only 12 . 0% (95% CI 8 . 1-17 . 4) of people with COPD reported a previous pulmonary function test. Risk factors for COPD included smoking exposure of 20 pack-years or more (odds ratio [OR] 1 . 95, 95% CI 1 . 53-2 . 47), exposure to annual mean particulate matter with a diameter less than 2 . 5 mu m of 50-74 mu g/m(3) (1 . 85, 1 . 23-2 . 77) or 75 mu g/m(3) or higher (2 . 00, 1 . 36-2 . 92), underweight (body-mass index <18 . 5 kg/m(2); 1 . 43, 1 . 03-1 . 97), sometimes childhood chronic cough (1 . 48, 1 . 14-1 . 93) or frequent cough (2 . 57, 2 . 01-3 . 29), and parental history of respiratory diseases (1 . 40, 1 . 23-1 . 60). A lower risk of COPD was associated with middle or high school education (OR 0 . 76, 95% CI 0 . 64-0 . 90) and college or higher education (0 . 47, 0 . 33-0 . 66). Interpretation Spirometry-defined COPD is highly prevalent in the Chinese adult population. Cigarette smoking, ambient air pollution, underweight, childhood chronic cough, parental history of respiratory diseases, and low education are major risk factors for COPD. Prevention and early detection of COPD using spirometry should be a public health priority in China to reduce COPD-related morbidity and mortality.

基金:
语种:
高被引:
热点:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2016]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Med, Beijing 100029, Peoples R China; [4]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [5]Chinese Acad Med Sci, Beijing, Peoples R China; [6]Peking Union Med Coll, Beijing, Peoples R China; [7]Capital Med Univ, Dept Resp Med, Beijing, Peoples R China; [8]WHO, Collaborating Ctr Tobacco Cessat & Resp Dis, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Med, Beijing 100029, Peoples R China; [4]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [5]Chinese Acad Med Sci, Beijing, Peoples R China; [6]Peking Union Med Coll, Beijing, Peoples R China; [7]Capital Med Univ, Dept Resp Med, Beijing, Peoples R China; [8]WHO, Collaborating Ctr Tobacco Cessat & Resp Dis, Beijing, Peoples R China; [30]Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院